Market Cap 59.56B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 18.20
Forward PE 17.06
Profit Margin 0.48%
Debt to Equity Ratio 3.45
Volume 1,141,700
Avg Vol 1,901,102
Day's Range N/A - N/A
Shares Out 194.56M
Stochastic %K 72%
Beta 0.58
Analysts Strong Sell
Price Target $349.46

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
OnlyFibs
OnlyFibs Jul. 7 at 3:56 AM
$COR is pushing higher toward $296.51 after delivering a solid Q2 fiscal 2026 print with revenue hitting $78.4B and raising full-year adjusted EPS guidance to $17.65-$17.90. Strategic contributions from the OneOncology integration are driving strong gross margin expansion in U.S. Healthcare Solutions. Discipline and key level defense remain our edge ahead of the upcoming Q3 earnings release on August 5. 🐂🎯 Bull Key Levels: Holding a firm base above $285.00 is vital to maintain upside momentum toward the $315.00 resistance pivot. 🐂🔥 Bear Key Levels: Slipping back under $268.00 exposes a structural retest of prior multi-month demand floors. 🐻⚠️ Take Profit Targets: $315.00 / $340.00. 💰💸#hovdid #COR #Cencora #Healthcare #Pharma #Trading
0 · Reply
SmartInsider
SmartInsider Jul. 2 at 4:33 AM
Cencora Inc - $COR on May 29th, 2026 Learn more: https://www.smartinsider.com/stock-of-the-week/cor-us-ranked-positive-on-may-29th-2026/ See disclaimer: https://www.smartinsider.com/disclaimer/
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 7:11 PM
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 7:02 PM
$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Roxy123321
Roxy123321 Jun. 23 at 4:59 PM
$COR Will this go up or come down to where it was before?
0 · Reply
G101SPM
G101SPM Jun. 23 at 2:29 PM
#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
0 · Reply
jontanaj
jontanaj Jun. 23 at 1:15 AM
$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
0 · Reply
jhalimath61
jhalimath61 Jun. 22 at 10:54 PM
$COR 300 in August
1 · Reply
FilingTracker
FilingTracker Jun. 22 at 8:09 PM
$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 12 at 4:03 PM
0 · Reply
Latest News on COR
Cencora price target raised to $285 from $280 at BofA

2026-06-24T11:00:13.000Z - 21 days ago

Cencora price target raised to $285 from $280 at BofA

CI MCK


Suncrete, Inc. Completes Arkansas Acquisition

Jun 15, 2026, 4:15 PM EDT - 4 weeks ago

Suncrete, Inc. Completes Arkansas Acquisition

RMIX


Cencora price target lowered to $350 from $425 at Barclays

2026-06-10T09:16:02.000Z - 5 weeks ago

Cencora price target lowered to $350 from $425 at Barclays


Cencora appoints Eva Boratto as CFO

2026-05-27T11:38:00.000Z - 7 weeks ago

Cencora appoints Eva Boratto as CFO


Cencora still sees long-term adjusted EPS growth of 10%-14%

2026-05-27T11:34:42.000Z - 7 weeks ago

Cencora still sees long-term adjusted EPS growth of 10%-14%


Cencora Announces Updated Fiscal Year 2026 Financial Outlook

May 21, 2026, 4:30 PM EDT - 7 weeks ago

Cencora Announces Updated Fiscal Year 2026 Financial Outlook


Cencora price target lowered to $339 from $420 at Baird

2026-05-07T16:03:22.000Z - 2 months ago

Cencora price target lowered to $339 from $420 at Baird


Cencora price target lowered to $300 from $360 at Evercore ISI

2026-05-07T13:57:35.000Z - 2 months ago

Cencora price target lowered to $300 from $360 at Evercore ISI


Cencora price target raised to $412 from $410 at UBS

2026-05-07T13:27:00.000Z - 2 months ago

Cencora price target raised to $412 from $410 at UBS


Cencora price target lowered to $355 from $405 at Citi

2026-05-07T11:17:45.000Z - 2 months ago

Cencora price target lowered to $355 from $405 at Citi


Cencora reports Q2 adjusted EPS $4.75, consensus $4.73

2026-05-07T09:39:48.000Z - 2 months ago

Cencora reports Q2 adjusted EPS $4.75, consensus $4.73


Cencora Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Cencora Earnings Call Transcript: Q2 2026


Cencora Earnings release: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Cencora Earnings release: Q2 2026


Cencora Slides: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Cencora Slides: Q2 2026


Cencora Quarterly report: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Cencora Quarterly report: Q2 2026


Cencora raises annual profit forecast despite quarterly miss

May 6, 2026, 7:41 AM EDT - 2 months ago

Cencora raises annual profit forecast despite quarterly miss


Cencora Reports Fiscal 2026 Second Quarter Results

May 6, 2026, 6:30 AM EDT - 2 months ago

Cencora Reports Fiscal 2026 Second Quarter Results


Cencora initiated with a Market Perform at William Blair

2026-04-28T10:11:54.000Z - 2 months ago

Cencora initiated with a Market Perform at William Blair


Cencora price target lowered to $360 from $420 at Evercore ISI

2026-04-08T13:22:35.000Z - 3 months ago

Cencora price target lowered to $360 from $420 at Evercore ISI


Cencora Announces Financial Leadership Transition

Mar 17, 2026, 8:30 AM EDT - 4 months ago

Cencora Announces Financial Leadership Transition


Cencora Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 4 months ago

Cencora Transcript: Leerink Global Healthcare Conference 2026


Cencora Transcript: AGM 2026

Mar 5, 2026, 3:30 PM EST - 4 months ago

Cencora Transcript: AGM 2026


Covetrus and MWI Animal Health to Merge

Feb 18, 2026, 7:00 AM EST - 5 months ago

Covetrus and MWI Animal Health to Merge


Cencora Closes $3.0 Billion Senior Notes Offering

Feb 13, 2026, 4:15 PM EST - 5 months ago

Cencora Closes $3.0 Billion Senior Notes Offering


Cencora Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Earnings Call Transcript: Q1 2026


Cencora Quarterly report: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Quarterly report: Q1 2026


Cencora Earnings release: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Earnings release: Q1 2026


Cencora Slides: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Slides: Q1 2026


Cencora Reports Fiscal 2026 First Quarter Results

Feb 4, 2026, 6:30 AM EST - 5 months ago

Cencora Reports Fiscal 2026 First Quarter Results


Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 6 months ago

Cencora Elects Ellen Cooper to Its Board of Directors


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 6 months ago

Cencora Proxy statement: Proxy Filing


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 6 months ago

Cencora Proxy statement: Proxy Filing


Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 6 months ago

Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference


Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 6 months ago

Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference


Cencora Earnings Call Transcript: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Earnings Call Transcript: Q4 2025


Cencora Annual report: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Annual report: Q4 2025


Cencora Earnings release: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Earnings release: Q4 2025


Cencora Slides: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Slides: Q4 2025


Cencora Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 11 months ago

Cencora Transcript: Baird Global Healthcare Conference 2025


Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 11 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors


Cencora Earnings Call Transcript: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q3 2025


Cencora Earnings release: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings release: Q3 2025


Cencora Quarterly report: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Quarterly report: Q3 2025


Cencora Slides: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Slides: Q3 2025


Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Third Quarter Results


Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 1 year ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q2 2025


Cencora Quarterly report: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Quarterly report: Q2 2025


Cencora Earnings release: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings release: Q2 2025


Cencora Slides: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Slides: Q2 2025


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 1 year ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings Call Transcript: Q1 2025


Cencora Quarterly report: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Quarterly report: Q1 2025


Cencora Earnings release: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings release: Q1 2025


Cencora Slides: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Slides: Q1 2025


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 1 year ago

Cencora raises 2025 profit forecast on specialty drug demand


OnlyFibs
OnlyFibs Jul. 7 at 3:56 AM
$COR is pushing higher toward $296.51 after delivering a solid Q2 fiscal 2026 print with revenue hitting $78.4B and raising full-year adjusted EPS guidance to $17.65-$17.90. Strategic contributions from the OneOncology integration are driving strong gross margin expansion in U.S. Healthcare Solutions. Discipline and key level defense remain our edge ahead of the upcoming Q3 earnings release on August 5. 🐂🎯 Bull Key Levels: Holding a firm base above $285.00 is vital to maintain upside momentum toward the $315.00 resistance pivot. 🐂🔥 Bear Key Levels: Slipping back under $268.00 exposes a structural retest of prior multi-month demand floors. 🐻⚠️ Take Profit Targets: $315.00 / $340.00. 💰💸#hovdid #COR #Cencora #Healthcare #Pharma #Trading
0 · Reply
SmartInsider
SmartInsider Jul. 2 at 4:33 AM
Cencora Inc - $COR on May 29th, 2026 Learn more: https://www.smartinsider.com/stock-of-the-week/cor-us-ranked-positive-on-may-29th-2026/ See disclaimer: https://www.smartinsider.com/disclaimer/
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 7:11 PM
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 7:02 PM
$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Roxy123321
Roxy123321 Jun. 23 at 4:59 PM
$COR Will this go up or come down to where it was before?
0 · Reply
G101SPM
G101SPM Jun. 23 at 2:29 PM
#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
0 · Reply
jontanaj
jontanaj Jun. 23 at 1:15 AM
$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
0 · Reply
jhalimath61
jhalimath61 Jun. 22 at 10:54 PM
$COR 300 in August
1 · Reply
FilingTracker
FilingTracker Jun. 22 at 8:09 PM
$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 12 at 4:03 PM
0 · Reply
cynicaloptimist
cynicaloptimist Jun. 8 at 12:50 AM
$COR 👁
0 · Reply
Cutlass
Cutlass Jun. 5 at 4:25 PM
$COR Another safe haven on red days - 🔎👀
0 · Reply
thefourpercent
thefourpercent Jun. 1 at 3:20 PM
$COR playing here again
0 · Reply
OnlyFibs
OnlyFibs Jun. 1 at 12:08 AM
$COR is an absolute cash-generating machine! Cencora just updated their fiscal 2026 outlook, raising EPS guidance and announcing a massive new $2.0 billion share repurchase program! The board is aggressively eating up their own float, and the market is officially waking up to the value here. Taking a look at the daily chart, this is a textbook reversal setup! Price found a hard bottom near the $242 level and is now violently hooking up with a powerful momentum shift off the lows. The tape has flipped, and it's coiling incredibly tight right below immediate overhead resistance! 📊🐋 🐂 Bulls: Need a decisive break and hold above the $271.00 resistance zone to spark a structural squeeze toward the $290 level! 🚀 🐻 Bears: A flush below the $250.00 support base traps the early dip buyers and resumes the heavy downtrend. 🛑 #COR #StockMarket #SwingTrading #hovdid
0 · Reply
jhalimath61
jhalimath61 May. 29 at 3:07 PM
$COR So 2Billion dollar buyback, guidance raised, insider buys 1 million on open market - and this is still going red. Such an easy buy at these levels. This is a beast of a healthcare stock and will be 300 plus in no time.
1 · Reply
thefourpercent
thefourpercent May. 28 at 1:05 PM
$COR order fulfilled
0 · Reply
thefourpercent
thefourpercent May. 28 at 11:42 AM
$COR I’m buying here expecting a 2% return this week
0 · Reply
DidYouReadThis
DidYouReadThis May. 26 at 4:04 PM
$OTLK $COR $ABC Oldie but a goodie
0 · Reply
OnlyFibs
OnlyFibs May. 25 at 10:23 PM
$COR is staging a violent V-shaped recovery after a catastrophic earnings gap-down, fueled by a massive new share repurchase program. 🌊 This is a high-conviction structural reset for the pharmaceutical distributor. While the top-line revenue miss and lowered guidance caused a historic haircut, management firing back with a $2B buyback authorization and raised EPS outlook has completely changed the algorithmic flow. Bottom-fishers are aggressively positioning for a mean-reversion squeeze back into the structural gap. 🎯 🐂 Bulls want to hold the 259.87 baseline to force a clean daily close over 274.91 targeting the heavy 289.02 supply block. 🐻 Bears need to crack 259.87 to kill the dead-cat bounce and trigger a retest of the 237.51 capitulation floor. 📊 Lean BULLISH. #cor #trading #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing May. 25 at 5:49 PM
$COR Current Stock Price: $275.05 Contracts to trade: $280.0 COR Jun 18 2026 Call Entry: $5.40 Exit: $10.66 ROI: 97% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OnlyFibs
OnlyFibs May. 23 at 9:23 PM
Massive macro inflection test developing on $COR. The weekly frame for Cencora has flushed straight back down into a heavy multi-year horizontal support zone on high capitulation volume. 💊📈 📊 The Tape Facts: Earnings Beat: Q2 adjusted EPS printed a clean beat at $4.75 on a monstrous $78.4B in revenue, fueled by surging GLP-1 distribution. Capital Defense: Management officially raised full-year EPS guidance to $17.65-$17.90 and dropped a $1.0B share buyback authorization. 🎯 Key Levels to Confirm: 🐂 Bulls: Must defend this base and close above $234.50 to activate the OneOncology acquisition momentum and target the $252.18 shelf. 🐻 Bears: Need a weekly close below $221.43 to break the macro support line and force a rapid markdown down to the $205.50 floor. #Healthcare #SpecialtyPharma #ValueInvesting #TechnicalAnalysis #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 22 at 4:17 AM
👀 $COR might’ve just printed the capitulation candle. Huge flush Massive volume spike Immediate bounce attempt That combo always gets my attention. 📈 Trend: Neutral 🐂 Bulls need $267 then $274 for real continuation 🐻 Lose $250 and this probably revisits lows Feels like weak hands got completely washed out here 😭🔥 Could see a violent relief rally if market stays green. #hovdid
0 · Reply